Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
暂无分享,去创建一个
Qin Guo | Andrea Crisanti | P. Burkhard | A. Crisanti | S. A. Kaba | D. Lanar | Yongkun Yang | C. Mittelholzer | Peter Burkhard | Roberta Spaccapelo | R. Spaccapelo | Stephen A. Kaba | Margaret E. McCoy | Tais A. P. F. Doll | Clara Brando | Debleena Dasgupta | Yongkun Yang | Christian Mittelholzer | David E. Lanar | Q. Guo | C. Brando | T. A. Doll | M. McCoy | D. Dasgupta
[1] A. Holder,et al. Function of Region I and II Adhesive Motifs ofPlasmodium falciparum Circumsporozoite Protein in Sporozoite Motility and Infectivity* , 2002, The Journal of Biological Chemistry.
[2] M. Levine,et al. Enhanced Immunity to Plasmodium falciparum Circumsporozoite Protein (PfCSP) by Using Salmonella enterica Serovar Typhi Expressing PfCSP and a PfCSP-Encoding DNA Vaccine in a Heterologous Prime-Boost Strategy , 2007, Infection and Immunity.
[3] J. Sattabongkot,et al. Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. , 1989, Science.
[4] U. Krzych,et al. Memory phenotype CD8+ T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium bergheisporozoites , 1999, European journal of immunology.
[5] D. Doolan,et al. Immune response to pre-erythrocytic stages of malaria parasites. , 2006, Current molecular medicine.
[6] J. Tam,et al. Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes. , 1992, Journal of immunology.
[7] David Leong,et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. , 2007, Molecular pharmaceutics.
[8] S. Raman,et al. Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles. , 2006, Nanomedicine : nanotechnology, biology, and medicine.
[9] A. Sette,et al. A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-γ and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery1 , 2002, The Journal of Immunology.
[10] M. Akashi,et al. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. , 2007, Biomaterials.
[11] Magdalena Plebanski,et al. Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity. , 2006, Methods.
[12] L. Rénia,et al. Plasmodium berghei-Infected Primary Hepatocytes Process and Present the Circumsporozoite Protein to Specific CD8+ T Cells In Vitro1 , 2007, The Journal of Immunology.
[13] Min Lu,et al. Atomic structure of a tryptophan-zipper pentamer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] Katrin Schwarz,et al. Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.
[15] D. Carucci,et al. Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults , 2011, PloS one.
[16] Sai T Reddy,et al. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[17] D. Carucci,et al. Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component , 2011, PloS one.
[18] P. Marrack,et al. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. , 1990, Science.
[19] Ueli Aebi,et al. A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria1 , 2009, The Journal of Immunology.
[20] J. Sattabongkot,et al. A Novel Chimeric Plasmodium vivax Circumsporozoite Protein Induces Biologically Functional Antibodies That Recognize both VK210 and VK247 Sporozoites , 2006, Infection and Immunity.
[21] O. Yang,et al. Human leukocyte antigen class I haplotypes of human immunodeficiency virus-1-infected persons on Likoma Island, Malawi. , 2011, Human immunology.
[22] Pedro Alonso,et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. , 2011, The New England journal of medicine.
[23] J. Stockman. First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children , 2013 .
[24] Andrea J. Radtke,et al. Dendritic Cells and Hepatocytes Use Distinct Pathways to Process Protective Antigen from Plasmodium in vivo , 2011, PLoS pathogens.
[25] Sai T Reddy,et al. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. , 2006, Trends in immunology.
[26] P. Marrack,et al. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. 1990. , 2010, Journal of immunology.
[27] S. Hay,et al. The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.
[28] L. Rénia,et al. Sterile Protection against Malaria Is Independent of Immune Responses to the Circumsporozoite Protein , 2007, PloS one.
[29] P. Romero,et al. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. , 1991, International immunology.
[30] W. Ripley Ballou,et al. Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ1 , 2003, The Journal of Immunology.
[31] David L. Tabb,et al. A proteomic view of the Plasmodium falciparum life cycle , 2002, Nature.
[32] S. Hoffman,et al. Boosting of DNA Vaccine-Elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites , 2005, Infection and Immunity.
[33] Andrew R. Jones,et al. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations , 2010, Nucleic Acids Res..
[34] Joe D. Cohen,et al. Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells , 2011, PloS one.
[35] R. Hartzman,et al. Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231. , 2000, Human immunology.
[36] V. Apostolopoulos,et al. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy. , 2007, Vaccine.
[37] D. Doolan,et al. Harnessing immune responses against Plasmodium for rational vaccine design. , 2011, Trends in parasitology.